Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab

Zhu, KY; Song, KW; Connors, JM; Leitch, H; Barnett, MJ; Ramadan, K; Slack, GW; Abou Mourad, Y; Forrest, DL; Hogge, DE; Nantel, SH; Narayanan, S; Nevill, TJ; Power, MM; Sanford, DS; Sutherland, HJ; Tucker, T; Toze, CL; Sehn, LH; Broady, R; Gerrie, AS

Gerrie, AS (reprint author), Univ British Columbia, Leukemia BMT Program BC, BC Canc, 2775 Laurel St,10th Floor, Vancouver, BC V5Z 1M9, Canada.

BRITISH JOURNAL OF HAEMATOLOGY, 2018; 181 (6): 782

Abstract

Treatment of Burkitt lymphoma (BL) with intensive, multi-agent chemotherapy with aggressive central nervous system (CNS) prophylaxis results in high c......

Full Text Link